MARKET

STXS

STXS

Stereotaxis Ord
AMEX
1.990
+0.160
+8.74%
Opening 13:44 03/17 EDT
OPEN
1.840
PREV CLOSE
1.830
HIGH
1.995
LOW
1.840
VOLUME
649.04K
TURNOVER
--
52 WEEK HIGH
3.290
52 WEEK LOW
1.660
MARKET CAP
169.79M
P/E (TTM)
-6.6868
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STXS last week (0310-0314)?
Weekly Report · 5h ago
Based on the provided financial report articles, I generated the title for the article: "Synthetics Technology Corporation (STXS) FY 2024 Financial Report: Revenue Growth, Product Concentration Risk, and Stock Performance" Please note that the title is generated based on the content provided, and it may not be the exact title used in the original article.
Press release · 2d ago
Weekly Report: what happened at STXS last week (0303-0307)?
Weekly Report · 03/10 12:10
Stereotaxis to Present at 37th Annual Roth Conference
Barchart · 03/10 07:02
Stereotaxis: Buy Rating Affirmed on Strong Financials and Promising Growth Outlook
TipRanks · 03/10 03:15
Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission
NASDAQ · 03/07 17:03
Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn
Seeking Alpha · 03/07 14:10
STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval
NASDAQ · 03/04 17:15
More
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Webull offers Stereotaxis Inc stock information, including AMEX: STXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STXS stock methods without spending real money on the virtual paper trading platform.